12/16/2024 6:00 AM | Cytosorbents (Issuer) MARIANI PETER J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2024 7:00 AM | Cytosorbents (Issuer) MARIANI PETER J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2024 6:17 AM | Cytosorbents (Filer)
| Form 424B5 | |
12/09/2024 6:18 AM | Cytosorbents (Subject)
| Form FWP | |
12/09/2024 6:08 AM | Cytosorbents (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/08/2024 8:00 PM | Capponi Vincent (Reporting) Cytosorbents (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/08/2024 8:00 PM | Cytosorbents (Issuer) Deliargyris Efthymios (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
10/01/2024 4:25 PM | Cytosorbents (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/01/2024 4:22 PM | Cytosorbents (Filer)
| Form 424B5 | |
10/01/2024 7:06 AM | Cytosorbents (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/30/2024 11:15 PM | Cytosorbents (Filer)
| Form EFFECT | |
09/26/2024 4:05 PM | Cytosorbents (Filer)
| Form S-3/A | |
08/20/2024 3:51 PM | Cytosorbents (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/16/2024 5:57 PM | Cytosorbents (Issuer) MARIANI PETER J (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/16/2024 5:58 PM | Cytosorbents (Issuer) MARIANI PETER J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2024 4:28 PM | Cytosorbents (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/16/2024 4:12 PM | Cytosorbents (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/26/2024 4:11 PM | Cytosorbents (Filer)
| Form 424B5 | |
07/26/2024 4:14 PM | Cytosorbents (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
07/03/2024 7:01 PM | Cytosorbents (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2024 3:31 PM | Cytosorbents (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/22/2024 3:35 PM | Cytosorbents (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 4:23 PM | Cytosorbents (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/19/2024 3:45 PM | Cytosorbents (Filer)
| Form DEF 14A | |
04/04/2024 8:45 PM | Chan Phillip P. (Reporting) Cytosorbents (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 8:45 PM | Cytosorbents (Issuer) Kim Jiny (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 8:45 PM | Capponi Vincent (Reporting) Cytosorbents (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 8:46 PM | BATOR MICHAEL G. (Reporting) Cytosorbents (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 8:46 PM | BLOCH KATHLEEN P. (Reporting) Cytosorbents (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 8:46 PM | Cytosorbents (Issuer) Sobel Alan D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 8:47 PM | Cytosorbents (Issuer) Deliargyris Efthymios (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 8:47 PM | Cytosorbents (Issuer) Jones Edward Raymond (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 5:06 AM | Cytosorbents (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2024 8:31 PM | BLOCH KATHLEEN P. (Reporting) Cytosorbents (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 8:32 PM | Capponi Vincent (Reporting) Cytosorbents (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 8:32 PM | Cytosorbents (Issuer) Deliargyris Efthymios (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 8:30 PM | Chan Phillip P. (Reporting) Cytosorbents (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 7:55 PM | Cytosorbents (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 3:42 PM | AVENIR CORP (Filed by) Cytosorbents (Subject)
| Form SC 13G | |
01/17/2024 4:20 PM | Cytosorbents (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 2:00 PM | Cytosorbents (Subject) Skylands Capital, LLC (Filed by)
| Form SC 13G | |
Missed Nvidia? Buy Elon Musk’s “Silent Partner” (Ad) In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks.
Today, it’s probably the most popular stock in the world.
I believe this Elon Musk “silent partner” could be the next big AI winner. So please click here to see the details because a lot of people could get rich. |
12/28/2023 3:49 PM | Cytosorbents (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/28/2023 3:49 PM | Cytosorbents (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |